rac-(S)-2-(1H-Imidazol-1-yl)-3-methyl­butan-1-ol

In the crystal structure of the title compound, C8H14N2O, inter­molecular O—H⋯N hydrogen bonds link mol­ecules related by translation along the a axis into chains. Weak inter­molecular C—H⋯O hydrogen bonds and C—H⋯π inter­actions enhance the crystal packing stability

Global Infectious Diseases in September 2022: Monthly Analysis

The threat of infectious diseases caused by pathogenic microorganisms to both human health and the economy is enormous. Coronavirus Disease 2019 (COVID-19) remains a global pandemic. In contrast to many other infectious diseases, monkeypox spreads rapidly and cannot be ignored. Collection of data on contagious diseases can provide quantitative evidence to support effective pandemic control strategies. Global data on predominant infectious diseases collected in the past several weeks and a summary of their epidemiology are presented herein

Global Infectious Diseases in October 2022: Monthly Analysis

Infectious diseases continue to pose a major threat to worldwide public health. Infections by Coronavirus Disease 2019 have eased but continue to negatively affect international economic development. The situation of other infectious diseases, such as monkeypox and mosquito-borne diseases, became stable in October. Monitoring epidemic situation of infectious diseases can provide rapid insight into global transmission trends and assist in predicting epidemic situations. Visualizations and analyses summarizing the past few weeks of global data on major infectious diseases are provided

Global Infectious Diseases in February 2023: Monthly Analysis

Public health security in human societies is placed under enormous strain by infectious disease epidemics. According to the WHO, COVID-19 and Mpox remain on the list of PHEICs, whereas cholera, dengue, and other contagious diseases remain endemic in several countries and regions. Data on prevalent infectious diseases have been collected worldwide in recent weeks, and may provide new ideas for international collaboration in public health

Isolation and characterization of the mink interferon-epsilon gene and its antiviral activity

The interferon (IFN) response is the first line of defense against viral invasion and thus plays a central role in the regulation of the immune response. IFN-epsilon (IFN-ε) is a newly discovered type I IFN that does not require viral induction, unlike other type I IFNs. IFN-ε is constitutively expressed in epithelial cells and plays an important role in mucosal immunity. In this study, we evaluated the biological activity of the mink-IFN (MiIFN)-ε gene in prokaryotic cells. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to evaluate IFN-ε expression in different mink tissues. MiIFN-ε was highly expressed in brain, lung, tracheal, kidney, intestinal, bladder, ovarian, and testis tissues. There was no significant difference in MiIFN-ε expression between female and male minks, except in the reproductive system. Expression of the small ubiquitin-like modifier (SUMO3)-MiIFN-ε fusion gene was induced by isopropylβ-d-thiogalactoside, and MiIFN-ε was collected after SUMO-specific protease digestion. We tested the antiviral activity of MiIFN-ε against vesicular stomatitis virus (VSV) in epithelial cells of feline kidney 81 (F81). We used qRT-PCR to analyze the expression of several IFN-stimulated genes (ISGs), including ISG15, 2′-5′ oligoadenylate synthetase (2′-5′OAS1), and myxovirus resistance protein 1 (Mx1). Recombinant IFN-ε induced high ISG expression in F81 cells. Compared with those in the cell control group, expressions of ISG15, Mx1, and 2′-5′ OAS1 in the VSV-GFP control, IFN-ε, and MiIFN-ε-inhibited VSV-GFP groups were significantly increased. Compared with those in the VSV-GFP control group, expressions of ISG15 and 2′-5′ OAS1 in the IFN-ε and MiIFN-ε-inhibited VSV-GFP groups were significantly increased, and the differences were highly significant (p < 0.0001). IFN-ε played an indirect antiviral role. These findings lay the foundation for detailed investigation of IFN-ε in the future

Global Infectious Diseases in March 2023: Monthly Analysis

Infectious diseases pose a major burden on public health and economic stability among societies worldwide. For centuries, they have been among the leading causes of death and disability, and are currently presenting growing challenges to health security and human progress. This report focuses on global outbreaks of infectious diseases, relying on Shusi Tech’s Global Epidemic Information Monitoring System to systematically summarize outbreak timing and location in infected populations from February 24, 2023, to March 23, 2023. Therefore, surveillance of infectious diseases on a continental scale is important to assess, recognize and protect against the risks that these diseases may pose to animal, domestic animal and human health on a global scale

Global Infectious Diseases in November 2022: Monthly Analysis

Infectious diseases, such as COVID-19 and monkeypox, pose a severe threat to economic development in all countries, as well as to the health of people everywhere. The World Health Organization and National Health Council epidemiological websites were used herein as data sources. Shusi Tech’s Global Epidemic Information Monitoring System was used to analyze the data for infectious diseases, determine changes in global epidemics, determine the distribution and quantity of infectious disease cases from October 24, 2022 to November 23, 2022, and analyze their changing trends. Furthermore, the analysis of these data can be used to predict prevalence rates, and assess epidemic prevention and control measures

Global Infectious Diseases in January 2023: Monthly Analysis

Infectious diseases are a major threat to global health and the economic stability of societies worldwide. To prevent outbreaks, monitoring the growth trends of infectious diseases appears to be particularly important and necessary. Herein, data from epidemiological websites, such as the World Health Organization and National Health Council are used to illustrate the outbreak trends for infectious diseases worldwide. In the context of the COVID-19 pandemic, a global resurgence in other infectious diseases has been observed, particularly influenza in the United States. Proper surveillance and effective strategies are urgently required to keep emerging infectious diseases under control

Global Infectious Diseases in April 2023: Monthly Analysis

Thousands of years have passed since infectious diseases first endangered human health as the most potentially lethal and debilitating diseases worldwide. The global incidence of infectious diseases has increased significantly over the past decades, such as COVID-19, cholera, dengue, and influenza. Key elements in combating and controlling diseases include monitoring and reporting infectious disease timelines and geographic distribution. We obtained surveillance data from Shusi Tech’s Global Epidemic Information Monitoring System and comprehensively analyzed the timing and location of outbreaks in infected populations from 24 March 2023 to 23 April 2023. Recent worldwide outbreaks of infectious diseases highlight the need to implement effective monitoring strategies and warning systems